Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

NEW YORK, Nov. 13, 2025 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer…

Health forum strengthens UK-Vietnam collaboration in digital health

The Health Innovation Business Forum, a key event for the United Kingdom’s health innovation trade mission…